Cargando…

Trends in overall mortality among US veterans with primary myelofibrosis

BACKGROUND: Primary myelofibrosis [PMF] is a myeloproliferative neoplasm associated with reduced overall survival (OS). Management strategies for PMF have evolved over the last two decades, including approval of ruxolitinib as the first Janus kinase 1 (JAK1)/JAK2 inhibitor for patients with intermed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tashi, Tsewang, Yu, Jingbo, Pandya, Shivani, Dieyi, Christopher, Scherber, Robyn, Parasuraman, Shreekant
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840363/ https://www.ncbi.nlm.nih.gov/pubmed/36641455 http://dx.doi.org/10.1186/s12885-022-10495-6

Ejemplares similares

Cytoreductive treatment patterns among US veterans with polycythemia vera
por: Parasuraman, Shreekant, et al.
Publicado: (2018)

Hematocrit levels and thrombotic events in patients with polycythemia vera: an analysis of Veterans Health Administration data
por: Parasuraman, Shreekant, et al.
Publicado: (2019)

Real-world survival of US patients with intermediate- to high-risk myelofibrosis: impact of ruxolitinib approval
por: Verstovsek, Srdan, et al.
Publicado: (2021)

Ruxolitinib Re-Treatment in Patients with Myelofibrosis: Real-World Evidence on Patient Characteristics and Outcomes
por: Gerds, Aaron T., et al.
Publicado: (2022)

Trends in Cardiovascular Disease Mortality in US Women Veterans vs Civilians
por: Ebrahimi, Ramin, et al.
Publicado: (2023)

Recruitment strategies and geographic representativeness for patient survey studies in rare diseases: Experience from the living with myeloproliferative neoplasms patient survey
por: Yu, Jingbo, et al.
Publicado: (2020)

Bone marrow fibrosis grade is an independent risk factor for overall survival in patients with primary myelofibrosis
por: Li, B, et al.
Publicado: (2016)

Development of a symptom assessment in patients with myelofibrosis: qualitative study findings
por: Mesa, Ruben A., et al.
Publicado: (2019)

Fibrocytes in primary myelofibrosis
por: Shimoda, Kazuya, et al.
Publicado: (2021)

Excess Mortality Among Patients in the Veterans Affairs Health System Compared With the Overall US Population During the First Year of the COVID-19 Pandemic
por: Weinberger, Daniel M., et al.
Publicado: (2023)

Timely Curative Treatment and Overall Mortality Among Veterans With Stage I NSCLC
por: Sanchez, Rolando, et al.
Publicado: (2022)

Primary Hypertrophic Osteoarthropathy With Myelofibrosis
por: Yousaf, Muhammad, et al.
Publicado: (2022)

Trends in Illness Severity, Hospitalization, and Mortality for Community-Onset Pneumonia at 118 US Veterans Affairs Medical Centers
por: Jones, Barbara E., et al.
Publicado: (2022)

Influenza and Pneumonia Mortality Across the 30 Biggest U.S. Cities: Assessment of Overall Trends and Racial Inequities
por: Lippert, Julia F., et al.
Publicado: (2021)

Relationship between symptom burden and disability leave among patients with myeloproliferative neoplasms (MPNs): findings from the Living with MPN patient survey
por: Yu, Jingbo, et al.
Publicado: (2019)

Circulating megakaryocyte in primary myelofibrosis: an uncommon finding in a myelofibrosis blood smear
por: Cantó, Pedro Asensi, et al.
Publicado: (2021)

Trends of lymphoma incidence in US veterans with rheumatoid arthritis, 2002–2017
por: Singh, Namrata, et al.
Publicado: (2020)

Real-World Outcomes Among US Veterans Health Administration Patients Newly Diagnosed with Metastatic Renal Cell Carcinoma and Treated with First-Line Monotherapy
por: Bhanegaonkar, Abhijeet, et al.
Publicado: (2021)

Unstable Housing and Mortality Among US Veterans Receiving Dialysis
por: Novick, Tessa K., et al.
Publicado: (2023)

Temporal trends of COVID-19 mortality and hospitalisation rates: an observational cohort study from the US Department of Veterans Affairs
por: Cai, Miao, et al.
Publicado: (2021)

Mortality Among US Veterans Admitted to Community vs Veterans Health Administration Hospitals for COVID-19
por: Ohl, Michael E., et al.
Publicado: (2023)

Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis
por: Tsutsui, Miyuki, et al.
Publicado: (2019)

Does angiogenesis matter in primary myelofibrosis?()
por: Campregher, Paulo Vidal
Publicado: (2014)

Primary myelofibrosis: current therapeutic options
por: de Melo Campos, Paula
Publicado: (2016)

The role of the extracellular matrix in primary myelofibrosis
por: Leiva, O, et al.
Publicado: (2017)

Myelofibrosis and Pancytopenia Associated With Primary Hyperparathyroidism
por: Rajan, Remya, et al.
Publicado: (2020)

Focus on Osteosclerotic Progression in Primary Myelofibrosis
por: Spampinato, Mariarita, et al.
Publicado: (2021)

Is it primary myelofibrosis or chronic megakaryocytic leukemia?
por: Lichtman, Marshall A.
Publicado: (2022)

Recent advances in therapies for primary myelofibrosis
por: Vainchenker, William, et al.
Publicado: (2023)

Seventeen-Year National Pain Prevalence Trends Among U.S. Military Veterans
por: Taylor, Kenneth Adam, et al.
Publicado: (2023)

Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients
por: Caramazza, D, et al.
Publicado: (2011)

Mortality among US veterans after emergency visits to Veterans Affairs and other hospitals: retrospective cohort study
por: Chan, David C, et al.
Publicado: (2022)

Development and Validation of an Inflammatory Bowel Disease Severity Index Using US Administrative Claims Data: A Retrospective Cohort Study
por: Chen, Grace, et al.
Publicado: (2020)

Evidence that Prefibrotic Myelofibrosis Is Aligned along a Clinical and Biological Continuum Featuring Primary Myelofibrosis
por: Barosi, Giovanni, et al.
Publicado: (2012)

Smoking Status and Factors associated with COVID-19 In-Hospital Mortality among US Veterans
por: Razjouyan, Javad, et al.
Publicado: (2021)

Impact of Myeloproliferative neoplasms on patients’ employment status and work productivity in the United States: results from the living with MPNs survey
por: Yu, Jingbo, et al.
Publicado: (2018)

Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis
por: Mesa, Ruben, et al.
Publicado: (2022)

Myelofibrosis
por: Passamonti, Francesco, et al.
Publicado: (2023)

Primary myelofibrosis and extramedullary blastic transformation with hemophagocytosis
por: Kim, Misung, et al.
Publicado: (2012)

Recent advances in the diagnosis and management of primary myelofibrosis
por: Takenaka, Katsuto, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hu3c5usbp0lmt7g5vdlqgr0bof